Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
273
datasets available to search
ShareScore release 0.9.0
Dataset results
273 results for “Human immunodeficiency virus”
Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimes
ClinicalTrials.gov study NCT03960645. IPD Sharing: YES. Countries: 3. Publications: 1.
Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)
ClinicalTrials.gov study NCT04982445. IPD Sharing: YES. Countries: 1. Publications: 0.
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults
ClinicalTrials.gov study NCT04493216. IPD Sharing: YES. Countries: 11. Publications: 2.
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
ClinicalTrials.gov study NCT00795717. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
ClinicalTrials.gov study NCT01246401. IPD Sharing: YES. Countries: 1. Publications: 5.
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1
ClinicalTrials.gov study NCT03227861. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Mainte
ClinicalTrials.gov study NCT01641809. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)
ClinicalTrials.gov study NCT03615183. IPD Sharing: YES. Countries: 1. Publications: 0.
A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese Men
ClinicalTrials.gov study NCT03422172. IPD Sharing: YES. Countries: 1. Publications: 1.
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed
ClinicalTrials.gov study NCT03110380. IPD Sharing: YES. Countries: 6. Publications: 2.
Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
ClinicalTrials.gov study NCT02076178. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers
ClinicalTrials.gov study NCT03060447. IPD Sharing: NO. Countries: 1. Publications: 0.
Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)
ClinicalTrials.gov study NCT03960541. IPD Sharing: YES. Countries: 1. Publications: 2.
A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults
ClinicalTrials.gov study NCT04900038. IPD Sharing: YES. Countries: 10. Publications: 1.
Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-
ClinicalTrials.gov study NCT04233879. IPD Sharing: YES. Countries: 13. Publications: 1.
Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
ClinicalTrials.gov study NCT03272347. IPD Sharing: YES. Countries: 4. Publications: 2.
Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)
ClinicalTrials.gov study NCT05393037. IPD Sharing: YES. Countries: 6. Publications: 1.
Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)
ClinicalTrials.gov study NCT04233216. IPD Sharing: YES. Countries: 18. Publications: 1.
Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults
ClinicalTrials.gov study NCT03739866. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
ClinicalTrials.gov study NCT01667731. IPD Sharing: Not stated. Countries: 2. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.